News and Updates

Indian pharma records 12% revenue growth in July despite sluggish unit sales. Discover the factors driving this price-led market shift in our latest report.

The WHO recommends the Ervebo vaccine for new clinical trials to combat Ebola. Learn how this move aims to improve outbreak response and vaccine efficacy.

Despite $8.9 billion in AI drug discovery investments, zero drugs have reached FDA approval. We analyze if the AI-driven biotech hype is nearing a reset.

The FDA has authorized CLiK Extra to protect livestock from New World screwworm. Learn how this new treatment improves parasite control for animals.

Maharashtra FDA has revoked a Pune-based pharma firm's license following the discovery of contaminated medicines and severe Good Manufacturing Practices lapses.

China is rapidly becoming a global leader in medical research. Learn how regulatory reforms and infrastructure growth are shaping its clinical trial sector.

BioVie shares plummet as Phase IIb study for Parkinson’s treatment NE3107 fails to meet primary endpoints in motor function improvement trials.

The rise of betting on clinical trial outcomes sparks ethical concerns among experts. Discover the risks these prediction markets pose to medical research.

Discover how AI is revolutionizing drug development, reducing the $2 billion cost of research, and accelerating the path to life-saving medical breakthroughs.

The FDA has approved Tudriqev for advanced melanoma, offering a new treatment pathway for patients who have developed resistance to anti-PD-1 therapies.